pH Pharma signed a collaboration and licensing agreement for ADC development with Immunome

구분 News작성일

pH Pharma, biotech, announced that collaboration and licensing agreement for ADC development made with Immunome, U.S. biotech 

(For more information, please refer to the link below)

http://m.mtn.co.kr/news/news_view.php?id=2019101715184816599